Phase 4 Fatty Liver Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Effect of a GnRH Analog on Hepatic Steatosis
EndometriosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver
Aristotle University Of Thessaloniki62 enrolled2 locationsNCT06523530
Recruiting
Phase 4
Quantifying Hepatic Mitochondrial Fluxes in Humans
Non-Alcoholic Fatty Liver DiseaseType 2 DiabetesMitochondrial Metabolism Disorders
The University of Texas Health Science Center at San Antonio60 enrolled2 locationsNCT05305287
Recruiting
Phase 4
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Type 2 DiabetesFatty Liver
Seoul National University Bundang Hospital120 enrolled1 locationNCT06989723
Recruiting
Phase 4
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
Type2 Diabetes MellitusNonalcoholic Fatty Liver Disease
Zhujiang Hospital100 enrolled1 locationNCT06449833
Recruiting
Phase 4
Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
Nonalcoholic Fatty Liver Disease
First Affiliated Hospital of Wenzhou Medical University1,500 enrolled5 locationsNCT06368882
Recruiting
Phase 4
Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism
Hypogonadism, MaleFatty LiverOverweight/Obesity+1 more
Alexandra Kautzky-Willer32 enrolled1 locationNCT03851627